Hong Kong Software Stock News

In late July 2026, Keymed Biosciences announced positive global Phase III results for CMG901 (sonesitatug vedotin, AZD0901) in CLDN18.2-positive advanced gastric and related cancers, alongside Breakthrough Therapy Designation in China for its bispecific antibody CM512 in chronic rhinosinusitis with nasal polyps. These developments highlight Keymed’s progress in both oncology and immunology, anchored by its AstraZeneca partnership and a growing late-stage pipeline of first-in-class or highly...

Harbour Centre Development entered this earnings season with a reputation as a deeply loss making stock that screens as cheap on discounted cash flow models. The share price at HK$4.55 has drifted only modestly in recent weeks, which suggests investors were waiting for a clearer profit story rather than trading the name aggressively. The headline from this half year result is simple. Revenue held near HK$705 million, yet the company still reported a net loss of HK$82 million and a basic loss...

The market has already marked Horizon Construction Development down over the past three months, yet today’s H1 2026 numbers pose a tougher question. The stock closed at HK$0.67 on 5 August after a flat week, while the headline is a construction group still grinding out profit on very slim economics. Net profit margin over the past year sits at just 1.6% and earnings are flattered by a one off gain of CN¥56.7m. For a stock trading on a 12.5x P/E, that mix of thin margins and non recurring...

Fortune Real Estate Investment Trust slipped to HK$4.74 by yesterday’s close, leaving the stock down about 6.5% over three months even after today’s H1 2026 earnings drop. The headline is not revenue, which sat around HK$1.65b over the past twelve months. The story is the profit hole that still has not closed. Fortune REIT remains loss making on a trailing basis. Analysts have published projections that indicate a possible swing back to positive earnings over the coming years. In the short...

Techtronic Industries just reminded investors why it carries a premium valuation. The stock came into the results with a trailing P/E of 25.6x and a strong 90 day return of 13.9%. After the print, the headline is simple: power tools and equipment demand supported record first half 2026 revenue of US$8.3b and net income of US$738m, with basic earnings per share of US$0.405. The gap investors now need to judge is clear. Profit momentum looks solid, while a rich valuation and expectations...

China’s new 20% tax on offshore trusts has put a timer on how wealthy families handle Hong Kong listed assets. Forced selling to raise cash, shifts in offshore wealth planning and changing attitudes to liquidity are all feeding into pricing for some Hong Kong stocks. For investors, this is less about the headline tax rate and more about who sits on the other side of that selling. This article walks through 3 Hong Kong listed stocks that appear particularly exposed to the news. All 3 face...

Last week, Star Plus Legend Holdings Limited's (HKG:6683) stock jumped 10%, but insiders who sold CN¥393m worth of...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Viewing insider transactions for China Oral Industry Group Holdings Limited's ( HKG:8406 ) over the last year, we see...

Insiders who bought CN¥547.7k worth of MetaLight Inc. ( HKG:2605 ) stock in the last year have seen some of their...

While Redco Properties Group Limited ( HKG:1622 ) shareholders have enjoyed a good week with stock up 11%, they need...

While Biosysen Limited ( HKG:1355 ) shareholders have had a good week with the stock up 28%, they shouldn't let their...

In July 2026, Kingboard Laminates Holdings reported unaudited earnings guidance for the six months ended June 30, 2026, expecting net profit of more than HK$2.80 billion, over triple the level a year earlier. The company attributed this profit surge to a tight supply backdrop that has lifted prices and volumes across laminates and key upstream materials, while highlighting the benefits of its vertically integrated model. We’ll now examine how this profit guidance, underpinned by tight...

Gravity Co., Ltd. recently announced that Ragnarok M: Eternal Love 2, co-developed with X.D. Network Inc., received a Chinese government ISBN code on July 23, 2026, clearing a key regulatory hurdle for its Mobile and PC launch in China. As the successor to a prior Ragnarok title that previously topped free downloads and reached the Apple App Store’s top-grossing ranks in China, the new 3D semi-open-world installment could become an important content milestone for XD’s game portfolio. We’ll...

Hang Lung Group earnings and dividend set the tone Hang Lung Group (SEHK:10) has just reported its half year 2026 results alongside an interim cash dividend announcement and a committee appointment for Chair Adriel Chan, giving investors fresh information on income, operations and governance. See our latest analysis for Hang Lung Group. At a share price of HK$13.55, Hang Lung Group has seen a 4.07% 1 month share price return, while the 90 day share price return is down 15.15% and the 3 year...

Lee & Man Paper Manufacturing stock has quietly delivered a strong few months, with the share price up about 32% over 90 days, yet today’s H1 2026 earnings remind you why the market has been willing to re-rate it. The headline is profit quality. Net income excluding extra items came in at HK$1,373.0m on revenue of HK$14,841.9m, and trailing 12‑month net profit margin sits at 8.6%, compared with 5.3% a year ago. For a cyclical paper producer, that kind of margin rebuild is what really moves...

Lee & Man Chemical stock has quietly put together a solid run, with the shares up about 20% over the past month and closing at HK$5.20 on 4 August. That set the stage for an earnings report where the headline was not the revenue line; it was the margin story. Net income of HK$349.5 million on HK$2,168.3 million of revenue in the first half of 2026 kept profitability looking steady in a sector where input costs and pricing power usually dominate sentiment. Is Lee & Man Chemical trading at a...

Kingboard Holdings (SEHK:148) issued fresh earnings guidance for the six months to 30 June 2026, flagging net profit of more than HK$2.7b, driven mainly by a sharp profit increase in its laminates segment. See our latest analysis for Kingboard Holdings. The new guidance lands after a volatile spell for Kingboard Holdings, with the share price falling 57.38% over the past month but still recording a 42.12% year to date share price return and a 54.97% total shareholder return over the past...

Why Newborn Town’s Updated Revenue Guidance Matters Now Newborn Town (SEHK:9911) issued new revenue guidance for the six months to 30 June 2026, flagging expected group revenue of about US$595 million to US$615 million, an increase of roughly 34.3% to 38.8% year on year. The company linked this expected range to combined contributions from its social networking business and its other newer business lines, which keeps attention on how these segments shape the stock’s appeal for investors. See...

In recent months, the Asian markets have been marked by a mix of volatility and opportunity, driven in part by global economic shifts and technological advancements. As investors navigate this landscape, growth companies with high insider ownership are particularly appealing due to their potential for strong alignment between management and shareholder interests.

As the Asian markets continue to navigate a complex landscape marked by fluctuating economic indicators and evolving market sentiment, small-cap stocks have emerged as intriguing opportunities for investors seeking growth potential. In this dynamic environment, identifying promising small-cap stocks involves assessing factors such as innovative business models, strong financial health, and adaptability to changing economic conditions.

Envision Greenwise Holdings Limited ( HKG:1783 ) announced strong profits, but the stock was stagnant. We did some...

InSilico Medicine Cayman TopCo (SEHK:3696) received FDA Fast Track Designation for ISM6331, an AI-generated pan-TEAD inhibitor for malignant pleural mesothelioma. The company secured NMPA IND approval for ISM8969/HT-001, a BBB-penetrant NLRP3 inhibitor for neuroinflammatory diseases such as Parkinson's, enabling parallel trials in China and Australia. InSilico Medicine Cayman TopCo launched a Drug Discovery and Development Benchmarks as a Service platform to measure AI and foundation model...

BYD stock has picked up recently after a weak 12 month stretch, yet the valuation checks and current market multiples still point to a mixed picture rather than a clear bargain or clear overvaluation. BYD shares are down 16.7% over the past year, which puts recent gains into context and raises the question of whether the current price fairly reflects the business outlook. Recent news on rising new energy vehicle sales and product launches can support expectations for future growth. The risk...